Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. Francis’ X-Stop Gets FDA Green Light To Treat Lumbar Spinal Stenosis

This article was originally published in The Gray Sheet

Executive Summary

St. Francis Medical Technologies will begin marketing the X-Stop non-fusion device for lumbar spinal stenosis in January to experienced surgeons in order to build the product's reputation
Advertisement

Related Content

Ortho Panel Green Lights VertiFlex’s Superion Spine Spacer
Increased CDRH Post-Approval Vigilance Plays Out In Medtronic X-Stop Trials
Increased CDRH Post-Approval Vigilance Plays Out In Medtronic X-Stop Trials
Kyphon Gains X Stop Spinal Stenosis Treatment Via $725 Mil. St. Francis Deal
St. Francis Keeps Brakes On X Stop Launch Despite Add-On Payment Victory
St. Francis And Cardica Try For New Technology Add-On Payments In FY ’07
UK Advisory Body Backs Endovascular Aneurysm Repair For Informed Patients
FDA Ortho Panel Gives Advice On Spinal Device Trial Design
FDA Ortho Panel Gives Advice On Spinal Device Trial Design
FDA Panel Doubts Lumbar Fusion Alternative’s Imaging Data
Advertisement
UsernamePublicRestriction

Register

MT022959

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel